Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112108594 | 11210859 | 4 | F | 201407 | 20160908 | 20150622 | 20160914 | EXP | PHHY2015CA070181 | NOVARTIS | 43.71 | YR | F | Y | 0.00000 | 20160914 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112108594 | 11210859 | 1 | PS | NEORAL | CYCLOSPORINE | 1 | Oral | 150 MG, BID | N | 50715 | 150 | MG | BID | ||||||
| 112108594 | 11210859 | 2 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | 200 MG, BID | N | 50715 | 200 | MG | BID | ||||||
| 112108594 | 11210859 | 3 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | 300 MG, QD | N | 50715 | 300 | MG | QD | ||||||
| 112108594 | 11210859 | 4 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | 200 MG, QD | N | 50715 | 200 | MG | QD | ||||||
| 112108594 | 11210859 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 450 MG, BIW | 6357.9834 | MG | 0 | 450 | MG | QOW | |||||
| 112108594 | 11210859 | 6 | C | VENTOLINE | ALBUTEROL | 1 | Unknown | N | 0 | ||||||||||
| 112108594 | 11210859 | 7 | C | ALVESCO | CICLESONIDE | 1 | Unknown | 1 DF(1 PUFF), BID | U | 0 | 1 | DF | BID | ||||||
| 112108594 | 11210859 | 8 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | 1 DF(1 PUFF), BID | U | 0 | 1 | DF | BID | ||||||
| 112108594 | 11210859 | 9 | C | ATARAX | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Unknown | N | 0 | ||||||||||
| 112108594 | 11210859 | 10 | C | CETRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | Unknown | 1 DF, BID | U | 0 | 1 | DF | TABLET | BID | |||||
| 112108594 | 11210859 | 11 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 112108594 | 11210859 | 12 | C | REACTINE /CAN/ | 2 | Unknown | 20 MG, BID | U | 0 | 20 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112108594 | 11210859 | 1 | Psoriasis |
| 112108594 | 11210859 | 2 | Eczema |
| 112108594 | 11210859 | 5 | Asthma |
| 112108594 | 11210859 | 6 | Product used for unknown indication |
| 112108594 | 11210859 | 7 | Product used for unknown indication |
| 112108594 | 11210859 | 8 | Product used for unknown indication |
| 112108594 | 11210859 | 9 | Product used for unknown indication |
| 112108594 | 11210859 | 10 | Product used for unknown indication |
| 112108594 | 11210859 | 11 | Product used for unknown indication |
| 112108594 | 11210859 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112108594 | 11210859 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112108594 | 11210859 | Asthma | |
| 112108594 | 11210859 | Blood immunoglobulin E increased | |
| 112108594 | 11210859 | Bronchitis | |
| 112108594 | 11210859 | Confusional state | |
| 112108594 | 11210859 | Cough | |
| 112108594 | 11210859 | Dermatitis atopic | |
| 112108594 | 11210859 | Diarrhoea | |
| 112108594 | 11210859 | Drug ineffective | |
| 112108594 | 11210859 | Eczema | |
| 112108594 | 11210859 | Erythema | |
| 112108594 | 11210859 | Forced expiratory volume decreased | |
| 112108594 | 11210859 | Injection site warmth | |
| 112108594 | 11210859 | Malaise | |
| 112108594 | 11210859 | Neutrophil count increased | |
| 112108594 | 11210859 | Overdose | |
| 112108594 | 11210859 | Platelet count increased | |
| 112108594 | 11210859 | Pruritus | |
| 112108594 | 11210859 | Rales | |
| 112108594 | 11210859 | Respiratory disorder | |
| 112108594 | 11210859 | Sinusitis | |
| 112108594 | 11210859 | Skin disorder | |
| 112108594 | 11210859 | Stress | |
| 112108594 | 11210859 | Vomiting | |
| 112108594 | 11210859 | Wheezing | |
| 112108594 | 11210859 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112108594 | 11210859 | 1 | 2014 | 0 | ||
| 112108594 | 11210859 | 2 | 2014 | 0 | ||
| 112108594 | 11210859 | 3 | 2014 | 0 | ||
| 112108594 | 11210859 | 4 | 2014 | 0 | ||
| 112108594 | 11210859 | 5 | 20150716 | 20160706 | 0 |